XML 30 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 4,176,351 $ 3,876,708
Marketable securities 5,223,472 11,830,252
Accounts receivable, net 777,871 780,237
Inventory, net 17,607,749 18,734,294
Other current assets 2,983,941 2,948,717
Total current assets 30,769,384 38,170,208
Property, plant and equipment, net of accumulated depreciation 21,025,616 22,847,854
Goodwill 4,736,771 4,422,928
Intangibles, net 3,660,930 3,764,063
Other assets 955,769 617,795
Total assets 61,148,470 69,822,848
Current liabilities:    
Accounts payable-trade 10,767,036 10,471,121
Accounts payable-related party   181,858
Lines of credit 7,944,270 9,806,002
Accrued commissions 4,485,547 3,740,846
Deferred revenue 3,154,541 1,661,851
Current portion of long-term debt 711,398 1,128,674
Other current liabilities 5,621,187 7,881,994
Total current liabilities 32,683,979 34,872,346
Long-term debt 25,694,232 25,594,722
Other long-term liabilities 889,164 499,640
Total liabilities 59,267,375 60,966,708
Commitments & contingencies      
Stockholders' equity    
Preferred stock, par value $0.001 per share, 500,000 authorized-0-issued and outstanding      
Common stock, par value $0.0001 per share, 250,000,000 and 250,000,000 shares authorized; 24,385,617 and 24,356,989 shares issued and outstanding, at June 30, 2014 and December 31, 2013, respectively 2,439 2,436
Additional paid-in capital 15,098,690 14,408,770
Accumulated other comprehensive loss (80,481) (767,569)
Accumulated deficit (19,767,575) (13,085,777)
Total stockholders' equity (deficit) attributable to CVSL stockholders' (4,746,927) 557,860
Stockholders' equity attributable to noncontrolling interest 6,628,022 8,298,280
Total stockholders' equity 1,881,095 8,856,140
Total liabilities and stockholders' equity $ 61,148,470 $ 69,822,848